BINV.ST
Price:
$45
Market Cap:
$2.96B
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated ...[Read more]
Industry
Biotechnology
IPO Date
2001-06-12
Stock Exchange
STO
Ticker
BINV.ST
According to BioInvent International AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -7.23. This represents a change of 52.29% compared to the average of -4.75 of the last 4 quarters.
The mean historical PE Ratio of BioInvent International AB (publ) over the last ten years is -12.57. The current -7.23 PE Ratio has changed 5.65% with respect to the historical average. Over the past ten years (40 quarters), BINV.ST's PE Ratio was at its highest in in the March 2016 quarter at 258.73. The PE Ratio was at its lowest in in the December 2016 quarter at -30.07.
Average
-12.57
Median
-6.02
Minimum
-57.85
Maximum
-3.55
Discovering the peaks and valleys of BioInvent International AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 544.92%
Maximum Annual PE Ratio = -3.55
Minimum Annual Increase = -93.86%
Minimum Annual PE Ratio = -57.85
Year | PE Ratio | Change |
---|---|---|
2023 | -3.55 | -93.86% |
2022 | -57.85 | 544.92% |
2021 | -8.97 | -47.82% |
2020 | -17.19 | 331.54% |
2019 | -3.98 | -29.08% |
2018 | -5.62 | -12.58% |
2017 | -6.43 | -47.17% |
2016 | -12.16 | 126.39% |
2015 | -5.37 | 17.91% |
2014 | -4.56 | -67.02% |
The current PE Ratio of BioInvent International AB (publ) (BINV.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.46
5-year avg
-18.31
10-year avg
-12.57
BioInvent International AB (publ)’s PE Ratio is less than Hansa Biopharma AB (publ) (-3.35), less than Saniona AB (publ) (-4.34), less than Active Biotech AB (publ) (-1.41), less than Oncopeptides AB (publ) (-1.67), less than Cantargia AB (publ) (-2.40),
Company | PE Ratio | Market cap |
---|---|---|
-3.35 | $2.19B | |
-4.34 | $355.41M | |
-1.41 | $173.85M | |
-1.67 | $438.37M | |
-2.40 | $547.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioInvent International AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioInvent International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioInvent International AB (publ)'s PE Ratio?
How is the PE Ratio calculated for BioInvent International AB (publ) (BINV.ST)?
What is the highest PE Ratio for BioInvent International AB (publ) (BINV.ST)?
What is the 3-year average PE Ratio for BioInvent International AB (publ) (BINV.ST)?
What is the 5-year average PE Ratio for BioInvent International AB (publ) (BINV.ST)?
How does the current PE Ratio for BioInvent International AB (publ) (BINV.ST) compare to its historical average?